Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
QuintilesIMS
Medtronic
Julphar
Mallinckrodt

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 5,952,547

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,952,547
Title: Modified Bacillus thuringiensis genes with improved expression in plant cells, methods of production on and use
Abstract:The invention relates to modified Bacillus thurigiensis genes with improved expression in plant cells, their preparation and uses. The invention relates more particularly to DNA fragments encoding all or part of a Bt insecticidal crystal protein, modified by translationally neutral modification(s) in cryptic promoter(s) and/or abortive intron(s). The invention also discloses method of preparing such modified DNAs, and methods of protecting plants from an insect pest.
Inventor(s): Cornelissen; Marc (Heusden, BE), Soetaert; Piet (Laarne, BE), Stam; Maike (Al Amstelveen, NL), Dockx; Jan (Turnhout, BE), Van Aarssen; Roel (Gent, BE)
Assignee: Plant Genetic Systems, N.V. (Brussels, BE)
Application Number:08/232,016
Patent Claims:see list of patent claims

Details for Patent 5,952,547

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Plant Genetic Systems, N.V. (Brussels, BE) 2016-09-14 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Plant Genetic Systems, N.V. (Brussels, BE) 2016-09-14 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Plant Genetic Systems, N.V. (Brussels, BE) 2016-09-14 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Medtronic
Chinese Patent Office
Boehringer Ingelheim
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.